ELUCENIA
Skip to content
ELUCENIA

ELUCENIA / Cancer atlas

Multiple myeloma

Clonal evolution, longitudinal follow-up and response definitions are central to myeloma research.

Editorial update · October 6, 2026

Context and biological diversity

Multiple myeloma is a plasma cell neoplasm. Precursor states, active disease and relapse are not interchangeable categories. Research should report diagnostic and response criteria, marrow characteristics, molecular alterations and sampling context, as well as previous treatment exposures.

What research makes it possible to study

CoMMpass brings together longitudinal clinical and molecular data from participants with myeloma, available through the Genomic Data Commons. Linking samples and follow-up enables exploration of changes during disease. As an observational resource, its strength lies in characterization; treatment differences and sample availability need consideration when interpreting results.

Application in a research project

An analysis can examine changes in clones and markers between diagnosis and progression without treating repeated samples as independent people. It should record data version, processing method and event definitions. For residual disease, material, sensitivity and assessment time are part of the result.

Research questions

Are persistent or emerging molecular alterations associated with different progression patterns?

Study design
Longitudinal analysis with paired samples, a prespecified progression definition and validation in an independent series.
What to measure
Alteration frequencies, time to progression, proportion with paired samples and missing data.
Interpretation limits
Repeat sampling may preferentially occur in participants with certain characteristics. A clonal association does not establish causation or indicate individual treatment.

Interpretation limits

Repeat sampling may preferentially occur in participants with certain characteristics. A clonal association does not establish causation or indicate individual treatment.

Original references

  1. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Health Professional Version
  2. Data From the MMRF’s Longitudinal Study and Other Projects Released
  3. NCI · Multiple myeloma

Continue exploring

Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology

What would you like to understand?

Search brings together public editorial content and tools. Results retain their review status.